Trials Sponsors Conditions Drugs Pricing

Conditions

Dyspnea Healthy Volunteers

Keywords

Dyspnea, High flow nasal cannula

Outcome Measures

Primary Outcomes (1)

Effects of high flow nasal cannula on strapping induced type of dyspnea
Evaluated by visual annylogic scale
One hour

Secondary Outcomes (1)

Compare the effect of the high flow by nasal cannula with and without oxygen on an experimental dyspnea, evaluated by the differences of changes in the visual analogic scale
One hour

Study Arms (2)

Oxygen first

EXPERIMENTAL

Optiflow with an inspired fraction of oxygen of 100% in the first seance Optiflow with an inspired fraction of oxygen of 21 % in the second seance

Device: Optiflow with an inspired fraction of oxygen of 100%Device: Optiflow with an inspired fraction of oxygen of 21%

Air first

EXPERIMENTAL

Optiflow with an inspired fraction of oxygen of 21 % in the first seance Optiflow with an inspired fraction of oxygen of 100 % in the second seance

Device: Optiflow with an inspired fraction of oxygen of 100%Device: Optiflow with an inspired fraction of oxygen of 21%

Interventions

Optiflow with an inspired fraction of oxygen of 100%Device

Respiratory gaz heated and humidified system of delivery with a fraction of oxygen inspired of 100%

Also known as: High flow nasal cannula with oxygen added

Air firstOxygen first

Optiflow with an inspired fraction of oxygen of 21%Device

Eligibility Criteria

Age18 Years - 70 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Healthy volunteers

You may not qualify if:

Sponsors & Collaborators

Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
Otherlead

Study Sites (2)

Laboratoire de Physiopathologie Respiratoire du Service de Pneumologie et de Réanimation

Paris, 75013, France

Service de Pneumologie et Réanimation Médicale

Paris, 75013, France

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

Capucine Morelot-Panzini, Doctor
Service de Pneumologie de la Pitié-Salpétrière
PRINCIPAL INVESTIGATOR
Thomas Similowski, PHD
Service de Pneumologie de la Pitié-Salpétrière
STUDY DIRECTOR

Enrollment

32 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: PARTICIPANT
Purpose: TREATMENT
Intervention Model: CROSSOVER
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

February 25, 2018

First Posted

March 19, 2018

Study Start

May 22, 2018

Actual (reported)

Effects on Experimental Dyspnea of High Flow Nasal Cannula

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Oxygen first

Air first

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (2)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Oxygen first

Air first

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (2)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations